Control

Critical analysis of the liver cancer policies and programs in China: implications for international liver cancer control | Global Health Research and Policy

Sia D, Villanueva A, Friedman SL, Llovet JM. Liver cancer cell of origin, molecular class, and effects on patient prognosis....

Fangzhou Launches Partnership for “AI + Hepatitis Prevention & Control Training Center” at the Greater Bay Area International Liver Disease Forum

GUANGZHOU, China, April 16, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven healthcare solutions,...